ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $329,000 | -34.2% | 15,075 | -9.9% | 0.01% | -36.4% |
| Q3 2021 | $500,000 | -54.8% | 16,731 | -32.9% | 0.01% | -54.2% |
| Q2 2021 | $1,105,000 | +3.6% | 24,948 | +3.7% | 0.02% | +4.3% |
| Q1 2021 | $1,067,000 | +69.1% | 24,054 | +109.2% | 0.02% | +91.7% |
| Q4 2020 | $631,000 | +37.2% | 11,500 | -42.9% | 0.01% | 0.0% |
| Q3 2020 | $460,000 | -8.5% | 20,127 | -16.2% | 0.01% | -14.3% |
| Q2 2020 | $503,000 | +49.3% | 24,024 | -0.6% | 0.01% | +7.7% |
| Q1 2020 | $337,000 | -25.9% | 24,171 | +20.9% | 0.01% | +85.7% |
| Q4 2019 | $455,000 | +95.3% | 20,000 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $233,000 | -8.6% | 20,000 | +17.6% | 0.01% | -28.6% |
| Q2 2019 | $255,000 | +16.4% | 17,000 | +36.0% | 0.01% | +40.0% |
| Q1 2019 | $219,000 | +5.8% | 12,500 | -10.7% | 0.01% | -44.4% |
| Q4 2018 | $207,000 | – | 14,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |